128 related articles for article (PubMed ID: 21325766)
21. Immunohistochemical detection of parathyroid hormone-related protein in a rare variant of hepatic neoplasm (sclerosing hepatic carcinoma).
Albar JP; De Miguel F; Esbrit P; Miranda R; Fernandez-Flores A; Sarasa JL
Hum Pathol; 1996 Jul; 27(7):728-31. PubMed ID: 8698319
[TBL] [Abstract][Full Text] [Related]
22. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
[TBL] [Abstract][Full Text] [Related]
23. An unusual complication following transarterial chemoembolization: acute myocardial infarction.
Lai YL; Chang WC; Kuo WH; Huang TY; Chu HC; Hsieh TY; Chang WK
Cardiovasc Intervent Radiol; 2010 Feb; 33(1):196-200. PubMed ID: 19730938
[TBL] [Abstract][Full Text] [Related]
24. Predictive factors of transarterial chemoembolisation toxicity in unresectable hepatocellular carcinoma.
Boulin M; Adam H; Guiu B; Aho LS; Cercueil JP; Di Martino C; Fagnoni P; Minello A; Jouve JL; Hillon P; Bedenne L; Lepage C
Dig Liver Dis; 2014 Apr; 46(4):358-62. PubMed ID: 24462550
[TBL] [Abstract][Full Text] [Related]
25. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
[TBL] [Abstract][Full Text] [Related]
26. The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
Lee JW; Yun M; Cho A; Han KH; Kim DY; Lee SM; Lee JD
Ann Nucl Med; 2015 Jun; 29(5):400-8. PubMed ID: 25652647
[TBL] [Abstract][Full Text] [Related]
27. Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma.
Kim SS; Nam JS; Cho HJ; Won JH; Kim JW; Ji JH; Yang MJ; Park JH; Noh CK; Shin SJ; Lee KM; Cho SW; Cheong JY
J Gastroenterol Hepatol; 2017 Jan; 32(1):199-207. PubMed ID: 27194671
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis.
Leng JJ; Xu YZ; Dong JH
ANZ J Surg; 2016 Oct; 86(10):816-820. PubMed ID: 25088384
[TBL] [Abstract][Full Text] [Related]
29. Dermatomyositis associated with hepatocellular carcinoma in an elderly female patient with hepatitis C virus-related liver cirrhosis.
Toshikuni N; Torigoe R; Mitsunaga M; Omoto A; Nakashima K
World J Gastroenterol; 2006 Mar; 12(10):1641-4. PubMed ID: 16570363
[TBL] [Abstract][Full Text] [Related]
30. Incidence, risk factors, and prognosis of acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma: a prospective cohort study.
Hao JF; Zhang LW; Bai JX; Li YJ; Liu JN; Zhang XL; Han JM; Li X; Jiang H; Cao N
Indian J Cancer; 2015 Feb; 51 Suppl 2():e3-8. PubMed ID: 25712839
[TBL] [Abstract][Full Text] [Related]
31. Value of 18-FDG-positron emission tomography/computed tomography before and after transarterial chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: initial results.
Cascales Campos P; Ramirez P; Gonzalez R; Febrero B; Pons JA; Miras M; Sanchez Bueno F; Robles R; Parrilla P
Transplant Proc; 2011; 43(6):2213-5. PubMed ID: 21839236
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Value of 18-Fluorodeoxyglucose-Positron Emission Tomography After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma Undergoing Orthotopic Liver Transplantation.
Cascales-Campos PA; Ramírez P; Lopez V; Gonzalez R; Saenz-Mateos L; Llacer E; Sánchez Bueno F; Robles R; Pons JA; Capel A; Frutos L; Navarro JL; Muñoz-Ramon P; Parrilla P
Transplant Proc; 2015 Oct; 47(8):2374-6. PubMed ID: 26518931
[TBL] [Abstract][Full Text] [Related]
33. PET/Computed Tomography in Evaluation of Transarterial Chemoembolization.
Ortega López N
PET Clin; 2015 Oct; 10(4):507-17. PubMed ID: 26384597
[TBL] [Abstract][Full Text] [Related]
34. Tumor hypercalcemia.
Roof BS
Calif Med; 1973 Jan; 118(1):35-6. PubMed ID: 4346690
[No Abstract] [Full Text] [Related]
35. How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma.
Hucke F; Pinter M; Graziadei I; Bota S; Vogel W; Müller C; Heinzl H; Waneck F; Trauner M; Peck-Radosavljevic M; Sieghart W
J Hepatol; 2014 Dec; 61(6):1287-96. PubMed ID: 25016222
[TBL] [Abstract][Full Text] [Related]
36. Cerebral Lipiodol Embolism in Hepatocellular Carcinoma Patients Treated with Transarterial Embolization/Chemoembolization.
Chu HJ; Lee CW; Yeh SJ; Tsai LK; Tang SC; Jeng JS
PLoS One; 2015; 10(6):e0129367. PubMed ID: 26107693
[TBL] [Abstract][Full Text] [Related]
37. Administration of bisphosphonates for malignant hepatic tumor with hypercalcemia.
Oida T; Mimatsu K; Kano H; Kawasaki A; Kuboi Y; Fukino N; Kida K; Amano S
Hepatogastroenterology; 2012; 59(114):444-7. PubMed ID: 22353513
[TBL] [Abstract][Full Text] [Related]
38. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
[TBL] [Abstract][Full Text] [Related]
39. [Hypercalcemia in patients with primary carcinoma of the liver without bone metastases (author's transl)].
Belaiche J; Vesin P; Kalifat R; Milhaud G; Cattan D
Arch Fr Mal App Dig; 1975; 64(1):21-9. PubMed ID: 169760
[No Abstract] [Full Text] [Related]
40. Manifestations of hypercholesterolaemia, hypoglycaemia, erythrocytosis and hypercalcaemia in patients with hepatocellular carcinoma: report of two cases.
Chu CW; Hwang SJ; Luo JC; Tsay SH; Li CP; Chang FY; Lee SD; Lui WY; Chiang JH
J Gastroenterol Hepatol; 1999 Aug; 14(8):807-10. PubMed ID: 10482434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
